Browse by author
Lookup NU author(s): Professor Adam ToddORCiD, Professor Andy HusbandORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Objectives To evaluate the utilisation of oxycodone in a tertiary care centre based in the North of England serving a population of 330 000. Methods A prospective study which gathered data from October 2011 to March 2012. Medical notes were screened to determine the prevalence of oxycodone use during the study period. The medication histories were determined; once the reason for oxycodone initiation was established, it was interpreted and classified as either appropriate or inappropriate. Results During the study period, a total of 51 patients were taking oxycodone; one patient was lost to follow-up. General practitioners were found to be the most common group responsible for initiating oxycodone (22 patients, 44%), followed by specialist palliative care nurses (11 patients, 22%). Other prescribers included palliative care consultants (nine patients, 18%); hospital doctors (seven patients, 14%) and a site-specific specialist nurse (one patient, 2%). Of the 50 patients, 17 (34%) were considered to be using oxycodone inappropriately. The most frequent reason for inappropriate use was initiating oxycodone without initially trying morphine. Conclusions Oxycodone is initiated inappropriately in a significant number of palliative care patients and should only be used as a second-line strong opioid or if morphine is not suitable or cannot be tolerated. The specialist palliative care team should be consulted for advice in cases of complex pain management.
Author(s): Todd A, Husband AK, Richardson R, Jassal N, Robson P, Andrew I
Publication type: Article
Publication status: Published
Journal: European Journal of Hospital Pharmacy
Year: 2013
Volume: 20
Issue: 2
Pages: 125-128
Print publication date: 30/10/2012
Online publication date: 05/04/2012
ISSN (print): 2047-9956
ISSN (electronic): 2047-9964
Publisher: BMJ Publishing
URL: https://doi.org/10.1136/ejhpharm-2012-000209
DOI: 10.1136/ejhpharm-2012-000209
Altmetrics provided by Altmetric